Live Breaking News & Updates on Rentschler Biotechnologie Gmb
Stay updated with breaking news from Rentschler biotechnologie gmb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biopharmaceutical CMO & CRO Market is Set To Fly High in Years to Come with AbbVie, LONZA, WuXi Biologics sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.
Biopharmaceuticals Contract Manufacturing Market Thriving Worldwide by 2027 | Samsung Biologics, Lonza Group AG, AbbVie Inc., Boehringer Ingelheim International GmbH, Merck KGaA sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.
Biopharmaceuticals Contract Manufacturing Market Thriving Worldwide by 2027 | Samsung Biologics, Lonza Group AG, AbbVie Inc., Boehringer Ingelheim International GmbH, Merck KGaA texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.
Business Development Executive in Biologics Drug Development and Manufacturing Brings More than 25 Years of Biopharmaceutical Industry Experience Selexis SA, a JSR Life Sciences company, has named ....
GENEVA (BUSINESS WIRE) Jun 1, 2021 Selexis SA, a JSR Life Sciences company, has named seasoned business development executive Roland Hoffmann-Hecht, PhD, as its new chief business officer. As a member of the companyâs executive leadership team, Dr. Hoffmann-Hecht will be responsible for all corporate and business development activities and will report directly to Selexis Chief Executive Officer Dirk Lange. (Photo: Business Wire) âWe are fortunate to welcome Roland to our executive leadership team given his expansive career in contract development and manufacturing organizations (CDMOs) serving the biopharmaceuticals industry and demonstrated success building valuable relationships with partners,â said Mr. Lange. âHis highly relevant skills and experience, coupled with his scientific and industry knowledge, will be invaluable to Selexis as we bolster our leading position in cell line development and ensure the continued success of our âGene-to- ....